STRS Ohio’s HilleVax HLVX Stock Holding History

STRS Ohio’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,000	Closed	-$49K	–	2012
2023 Q1	$49K	Hold	3,000	–	–	﹤0.01%	1788
2022 Q4	$50K	Hold	3,000	–	–	﹤0.01%	1807
2022 Q3	$51K	Hold	3,000	–	–	﹤0.01%	1827
2022 Q2	$32K	Buy	+3,000	New	+$35.6K	﹤0.01%	1921

Other funds holding HLVX

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

STRS Ohio's HLVX Position: Q2 2023 in Review

STRS Ohio sold out of HilleVax (HLVX) in Q2 2023, closing a stake of 3,000 shares — an estimated $49K sold.

STRS Ohio first reported a position in HLVX in Q2 2022 and held it in 4 quarters. The position peaked at $51K in Q3 2022. 54 funds tracked by Wall St. Rank hold HLVX as of Q2 2023.

STRS Ohio reported no remaining HilleVax position as of Q2 2023 after selling out during the quarter.
STRS Ohio sold 3,000 HilleVax shares in Q2 2023, an estimated $49K.
STRS Ohio first reported a position in HilleVax in Q2 2022 and held it in 4 quarters.
STRS Ohio's HilleVax position peaked at $51K in Q3 2022.
54 funds tracked by Wall St. Rank held HilleVax as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.